Research Comparison
NAD+ (Nicotinamide Adenine Dinucleotide) vs Pinealon (EDR)
A side-by-side research comparison of NAD+ (Nicotinamide Adenine Dinucleotide) and Pinealon (EDR) drawn from Cobalt Peptides' peptide database records.
NAD+ (Nicotinamide Adenine Dinucleotide)
Nicotinamide Adenine Dinucleotide (NAD+) is an essential coenzyme present in all living cells, playing a central role in energy production, DNA repair, and cellular metabolism. It functions as a key redox carrier, cycling between oxidized (NAD+) and reduced (NADH) states to drive mitochondrial ATP production. NAD+ levels decline significantly with age (up to ~10–50% across tissues), contributing to reduced mitochondrial efficiency, increased oxidative stress, and impaired cellular repair. Injectable NAD+ bypasses oral absorption limitations, providing immediate systemic availability and rapid cellular uptake.
Pinealon (EDR)
Pinealon (Glu-Asp-Arg/EDR) is a synthetic tripeptide bioregulator developed in Russia that demonstrates unique DNA-interaction capabilities for neuroprotection and cognitive enhancement. Research suggests benefits for traumatic brain injury recovery, age-related cognitive decline, and cellular aging processes through direct gene expression modulation. Studies have shown that Pinealon exerts neuroprotective effects through MAPK/ERK pathway modulation, reduced neuroinflammation, and enhanced NMDA receptor expression in hippocampal regions. Its ability to directly interact with DNA and influence gene expression makes it distinct from other peptide bioregulators.